Oral Cavity Verrucous Carcinoma — Trials

Oral Cavity Verrucous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: ECOG-ACRIN Cancer Research Group
Termination share: 46.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 51–54 of 54 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00023959	Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer	completed	Phase 1	39	National Cancer Institute (NCI)NIH	1	Feb 7, 2013	clinicaltrials
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	completed	Phase 1	75	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials